Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Power Corporation of Canada (PCR.F)

Compare
32.60
+0.20
+(0.62%)
At close: April 4 at 8:02:48 AM GMT+2
Loading Chart for PCR.F
  • Previous Close 32.40
  • Open 32.60
  • Bid 32.20 x 15000
  • Ask 32.80 x 15000
  • Day's Range 32.60 - 32.60
  • 52 Week Range 24.00 - 33.20
  • Volume 45
  • Avg. Volume 34
  • Market Cap (intraday) 20.936B
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) 11.90
  • EPS (TTM) 2.74
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield 1.57 (4.83%)
  • Ex-Dividend Date Mar 31, 2025
  • 1y Target Est --

Power Corporation of Canada, an international management and holding company, engages in the provision of financial services in North America, Europe, and Asia. It operates through Lifeco, IGM Financial, and GBL segments. The company offers life, health and dental, disability, critical illness, and creditor insurance, as well as reinsurance products; retirement and wealth management solutions, including annuities and segregated funds; and pension and investment products to individuals and small business owners. It is also involved in wealth and asset management for supporting financial advisors; listed and private investments, and alternative assets and third-party asset management; and fintech investments. The company was incorporated in 1925 and is based in Montreal, Canada. Power Corporation of Canada operates as a subsidiary of Pansolo Holding Inc.

www.powercorporation.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PCR.F

View More

Performance Overview: PCR.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

PCR.F
12.84%
S&P/TSX Composite index (^GSPTSE)
5.80%

1-Year Return

PCR.F
37.85%
S&P/TSX Composite index (^GSPTSE)
5.18%

3-Year Return

PCR.F
47.39%
S&P/TSX Composite index (^GSPTSE)
5.02%

5-Year Return

PCR.F
269.11%
S&P/TSX Composite index (^GSPTSE)
79.26%

Compare To: PCR.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PCR.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    20.94B

  • Enterprise Value

    34.07B

  • Trailing P/E

    11.87

  • Forward P/E

    9.35

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    2.38

  • Enterprise Value/Revenue

    1.33

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.68%

  • Return on Assets (ttm)

    0.47%

  • Return on Equity (ttm)

    10.79%

  • Revenue (ttm)

    36.39B

  • Net Income Avi to Common (ttm)

    2.81B

  • Diluted EPS (ttm)

    2.74

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    188.54B

  • Total Debt/Equity (mrq)

    61.32%

  • Levered Free Cash Flow (ttm)

    -13.64B

Research Analysis: PCR.F

View More

Company Insights: PCR.F

Research Reports: PCR.F

View More

People Also Watch